ArticleCancers2025
Efficacy of Adjuvant Chemotherapy for T1-2 Stage III Colorectal Cancer.
Hiromichi Maeda, Koji Oba, Kosuke Kashiwabara, Toru Aoyama, Shuhei Mayanagi, Mitsuro Kanda, Michitaka Honda, Masaru Muto, Junichi Sakamoto, Hisakazu Yamagishi and 1 more
Abstract read
In one paragraphArticle in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Hiromichi MaedaDepartment of Surgery, Kochi Medical School, Nankoku 783-8505, Japan.
Koji ObaDepartment of Biostatistics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.ORCID 0000-0001-5468-8988 Kosuke KashiwabaraData Science Office, Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Toru AoyamaDepartment of Surgery, Yokohama City University, Yokohama 236-0004, Japan.
Shuhei MayanagiDivision of Esophageal Surgery, Shizuoka Cancer Center Hospital, Shizuoka 411-8777, Japan.
Mitsuro KandaDepartment of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Michitaka HondaDepartment of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima 960-1247, Japan.
Masaru MutoJapanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo 136-0071, Japan.
Junichi SakamotoJapanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo 136-0071, Japan.ORCID 0000-0002-9675-512X Hisakazu YamagishiJapanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo 136-0071, Japan.
Takaki YoshikawaDepartment of Gastric Surgery, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Funding
the Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC) and the nonprofit organization Epidemiological & Clinical Research Information Network (ECRIN) number not provided
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
adjuvant chemotherapycolorectal cancerT1T2
Identifiers
PMID41375057
PMCPMC12691357
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390